HighsLab
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
HighsLab - overview
Established
2021
Location
Shenzhen, Guangdong, China
Primary Industry
Pharmaceuticals
About
Founded in 2021 and based in Shenzhen, China, HighsLab is a medical technology company that focuses on drug research and development and providing candidate drug transfer business. In February 2025, the firm raised venture funding from new investors Bioching Capital, Fosun Health Capital, and Hangzhou Qianhe Private Equity Fund Management. The company's main business includes drug research and development and transfer of drug candidates. It also provides medical technology consulting services.
The company’s revenue is generated by providing drugs.
Current Investors
Bioching Capital, Fosun Health Capital, Hangzhou Qianhe Private Equity Fund Management
Primary Industry
Pharmaceuticals
Sub Industries
Consulting Services, Pharmaceutical Research & Development
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.